Oi T. Wong

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers

Gary Tong, Junsheng Wang, Oleksandr Sverdlov et al. · Clinical Therapeutics · 2012 · 65 citations

Single-ascending Dose Study, Therapeutic Drug Monitoring, Pharmacology +9

Electrolyte output, blood pressure, and family history of hypertension

P Pietinen, Oi T. Wong, AM Altschul · American Journal of Clinical Nutrition · 1979 · 59 citations · Full text

Electrolytes, Hypertension, Electrolyte Disorder +4

A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

Randy Dockens, Junsheng Wang, Lorna Castaneda et al. · Clinical Pharmacokinetics · 2012 · 47 citations

Drug Safety, Pharmacological Study, Elderly Subjects +6

Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men

Gary Tong, Lorna Castaneda, Junsheng Wang et al. · Clinical Drug Investigation · 2012 · 35 citations

Neurobiology Of Disease, Alzheimer's Disease, Single Doses +6

Antineoplastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells.

I.H. Hall, Oi T. Wong, Rupendra Simlot et al. · PubMed · 1992 · 28 citations

Acute Toxicity Studies, Medicinal Chemistry, Oncology +14